Ashizawa N - Search Results

1

Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers.

Yanagihara Y, Ohtani M, Kariya S, Uchino K, Hiraishi T, Ashizawa N, Aoyama T, Yamamura Y, Yamada Y, Iga T. Yanagihara Y, et al. Among authors: ashizawa n. Biopharm Drug Dispos. 2003 Jan;24(1):37-43. doi: 10.1002/bdd.336. Biopharm Drug Dispos. 2003. PMID: 12516077

2

[Preparation of ketamine tablets for treatment of patients with neuropathic pain].

Yanagihara Y, Ohtani M, Matsumoto M, Kariya S, Uchino K, Hiraishi T, Ashizawa N, Aoyama T, Yamamura Y, Iga T. Yanagihara Y, et al. Among authors: ashizawa n. Yakugaku Zasshi. 1999 Dec;119(12):980-7. doi: 10.1248/yakushi1947.119.12_980. Yakugaku Zasshi. 1999. PMID: 10630103 Clinical Trial. Japanese.

3

[Effect of epidural buprenorphine on postoperative respiratory function].

Ichiishi N, Hiraishi T, Hara O, Konishi R, Osamura Y, Ashizawa N, Hanaoka K. Ichiishi N, et al. Among authors: ashizawa n. Masui. 1992 Oct;41(10):1574-9. Masui. 1992. PMID: 1433831 Japanese.

4

[A case report of central alveolar hypoventilation syndrome (Ondine's curse)].

Hiraishi T, Kawaguchi T, Ashizawa N, Chizuka M, Osamura Y. Hiraishi T, et al. Among authors: ashizawa n. Masui. 1984 Feb;33(2):183-8. Masui. 1984. PMID: 6716650 Japanese. No abstract available.

5

Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.

Ashizawa N, Yoshida M, Sugiyama Y, Akaike N, Ohbayashi S, Aotsuka T, Abe N, Fukushima K, Matsuura A. Ashizawa N, et al. Jpn J Pharmacol. 1997 Feb;73(2):133-44. doi: 10.1254/jjp.73.133. Jpn J Pharmacol. 1997. PMID: 9074947 Free article.

6

Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.

Yoshida M, Sugiyama Y, Akaike N, Ashizawa N, Aotsuka T, Ohbayashi S, Matsuura A. Yoshida M, et al. Among authors: ashizawa n. Diabetes Res Clin Pract. 1998 May;40(2):101-12. doi: 10.1016/s0168-8227(98)00032-1. Diabetes Res Clin Pract. 1998. PMID: 9681275

7

Diltiazem facilitates endothelin clearance from the blood stream to reduce toxic elevation of plasma endothelin level in rodents.

Ashizawa N, Okumura H, Matsuura A, Kobayashi F. Ashizawa N, et al. J Pharm Pharmacol. 1994 Mar;46(3):200-4. doi: 10.1111/j.2042-7158.1994.tb03778.x. J Pharm Pharmacol. 1994. PMID: 8027928

8

Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors.

Matsuura A, Okumura H, Asakura R, Ashizawa N, Takahashi M, Kobayashi F, Ashikawa N, Arai K. Matsuura A, et al. Among authors: ashizawa n. Jpn J Pharmacol. 1993 Oct;63(2):187-93. doi: 10.1254/jjp.63.187. Jpn J Pharmacol. 1993. PMID: 8283829 Free article.

9

An enzymatic assay for myo-inositol in tissue samples.

Ashizawa N, Yoshida M, Aotsuka T. Ashizawa N, et al. J Biochem Biophys Methods. 2000 Jul 10;44(1-2):89-94. doi: 10.1016/s0165-022x(00)00069-5. J Biochem Biophys Methods. 2000. PMID: 10889279

10

Inhibitory activities of metal chelators on endothelin-converting enzyme. I. In vitro studies.

Ashizawa N, Okumura H, Kobayashi F, Aotsuka T, Takahashi M, Asakura R, Arai K, Matsuura A. Ashizawa N, et al. Biol Pharm Bull. 1994 Feb;17(2):207-11. doi: 10.1248/bpb.17.207. Biol Pharm Bull. 1994. PMID: 8205117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page